- Country: South Korea
- Summary: (New Drug) Purchase of Ht Molecular Interaction Analysis System Based on Surface Plasmon Spectroscopy and Interferometry
- KRT Ref No: 109647031
- Deadline: 18 Nov 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: KRW 581818182
- Notice Type: Tender
- Document Ref. No.: 20241104289-00
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- (New drug) Purchase of HT molecular interaction analysis system based on surface plasmon spectroscopy and interferometry
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN(New Drug) Purchase of Ht Molecular Interaction Analysis System Based on Surface Plasmon Spectroscopy and Interferometry - Korea Tender
The OSONG ADVANCED MEDICAL INDUSTRY PROMOTION FOUNDATION, a Government sector organization in South Korea, has announced a new tender for (New Drug) Purchase of Ht Molecular Interaction Analysis System Based on Surface Plasmon Spectroscopy and Interferometry. This tender is published on KoreaTenders under KRT Ref No: 109647031 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-11-18.
The estimated tender value is KRW 581818182, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
